Weight loss “wonder drug” Wegovy will cost Irish users around €220 a month as it is not currently availably under either the ...

The injectable drug and others like it have become extremely popular in recent years as a way to manage diabetes and lose a significant weight. In recent months, it’s become desirable among those who ...

Stocks got a mid-week boost after the Federal Reserve kept interest rates unchanged. However, a poor earnings report from FedEx Inc. (NYSE: FDX) had stocks drifting lower and set for another week of ...

As China embarks on its three-year "weight management" campaign, Novo Nordisk has stepped forward with its powerful tools to ...

With Keytruda, the best-selling drug in the world, facing the end of exclusivity in 2028, BioSpace looks at five drugs that ...

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

Now that the shortage of semaglutide injection products has been resolved, the Food and Drug Administration (FDA) will restrict third parties ...

The device, dubbed NPM-115, is a miniature sub-dermal implant ... Participants will first be given injections of Novo Nordisk’s popular GLP-1RA medication Wegovy (semaglutide) for two months, then one ...

Google’s refreshed and more powerful Find My Device network officially debuted in April 2024. It uses crowdsourced information, such as Bluetooth and location proximity data, to help users find ...

ABC News' Dr. Tara Narula shares what patients need to know. Most compounded versions of popular drugs used for weight loss including Wegovy and Zepbound may soon no longer be available after a U ...

Novo Nordisk’s weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom received a warning letter from FDA.

Wegovy and Ozempic are part of a class of popular ... problems the FDA identified at the facilities. Dexcom produces devices called continuous glucose monitors that can help users track their ...